Location: New York, NY
CIK: 0001822947 · Show all filings
Period: Q4 2021 (← Previous) (Next →)
Filing Date: Feb 14, 2022
Total Value: $286M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| NTRA | NATERA INC | 268,000 | $25.03M | 8.7% | $92.26 | +12.5% | COM | 632307104 |
| ARVN | ARVINAS INC | 230,000 | $18.89M | 6.6% | $57.28 | +42.1% | COM | 04335A105 |
| RGEN | REPLIGEN CORP | 70,000 | $18.54M | 6.5% | $181.94 | +48.1% | COM | 759916109 |
| — | ISOPLEXIS CORP | 1,770,118 | $16.27M | 5.7% | $9.19 | — | COM | 465005106 |
| FATE | FATE THERAPEUTICS INC | 270,000 | $15.8M | 5.5% | $63.35 | -10.5% | COM | 31189P102 |
| COGT | COGENT BIOSCIENCES INC | 1,501,591 | $12.88M | 4.5% | $10.99 | -20.9% | COM | 19240Q201 |
| — | MIRATI THERAPEUTICS INC | 85,000 | $12.47M | 4.4% | $161.53 | — | COM | 60468T105 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 604,774 | $11.96M | 4.2% | $18.20 | +2.3% | COM | 92790C104 |
| — | SYROS PHARMACEUTICALS INC | 3,539,895 | $11.54M | 4.0% | $9.70 | — | COM | 87184Q107 |
| SRPT | SAREPTA THERAPEUTICS INC | 120,000 | $10.81M | 3.8% | $85.49 | 0.0% | COM | 803607100 |
| GH | GUARDANT HEALTH INC | 105,000 | $10.5M | 3.7% | $103.43 | 0.0% | COM | 40131M109 |
| NUVB | NUVATION BIO INC | 1,197,152 | $10.18M | 3.6% | $11.18 | -17.8% | COM CL A | 67080N101 |
| IDYA | IDEAYA BIOSCIENCES INC | 430,000 | $10.16M | 3.6% | $20.80 | +11.7% | COM | 45166A102 |
| LNTH | LANTHEUS HLDGS INC | 330,000 | $9.534M | 3.3% | $26.60 | 0.0% | COM | 516544103 |
| — | SOMALOGIC INC | 800,000 | $9.312M | 3.3% | $12.39 | — | CLASS A COM | 83444K105 |
| — | IVERIC BIO INC | 550,000 | $9.196M | 3.2% | $16.50 | — | COM | 46583P102 |
| — | NANOSTRING TECHNOLOGIES INC | 185,000 | $7.813M | 2.7% | $64.79 | — | COM | 63009R109 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 406,986 | $7.769M | 2.7% | $39.90 | -44.8% | COM | 462260100 |
| NTLA | INTELLIA THERAPEUTICS INC | 65,000 | $7.686M | 2.7% | $36.31 | +245.0% | COM | 45826J105 |
| NAUT | NAUTILUS BIOTECHNOLOGY INC | 1,225,060 | $6.346M | 2.2% | $10.83 | -50.6% | COM | 63909J108 |
| SGHT | SIGHT SCIENCES INC | 342,304 | $6.014M | 2.1% | $32.87 | -33.3% | COM | 82657M105 |
| — | LEAP THERAPEUTICS INC | 1,815,000 | $5.881M | 2.1% | $3.75 | — | COM | 52187K101 |
| GOSS | GOSSAMER BIO INC | 475,000 | $5.372M | 1.9% | $8.67 | +37.0% | COM | 38341P102 |
| — | JOUNCE THERAPEUTICS INC | 575,000 | $4.801M | 1.7% | $8.35 | — | COM | 481116101 |
| RPID | RAPID MICRO BIOSYSTEMS INC | 437,960 | $4.66M | 1.6% | $20.66 | -24.4% | CLASS A COM | 75340L104 |
| STOK | STOKE THERAPEUTICS INC | 185,000 | $4.438M | 1.6% | $23.86 | 0.0% | COM | 86150R107 |
| — | MEDAVAIL HOLDINGS INC | 2,920,780 | $4.089M | 1.4% | $15.05 | — | COM | 58406B103 |
| — | VERVE THERAPEUTICS INC | 110,360 | $4.069M | 1.4% | $38.25 | — | COM | 92539P101 |
| — | CYTEIR THERAPEUTICS INC | 319,538 | $3.633M | 1.3% | $21.40 | — | COM | 23284P103 |
| MGNX | MACROGENICS INC | 30,000 | $482K | 0.2% | $25.69 | -26.7% | COM | 556099109 |